FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeMaisa Yoshimoto, Jeremy A. Squire, Isabela Werneck da Cunha et al.|British Journal of Cancer|2007Cited by 294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcomeMaisa Yoshimoto, Jeremy A. Squire, Isabela Werneck da Cunha et al.|Modern Pathology|2008Cited by 278
MP-17.17: FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeMaisa Yoshimoto, Jeremy A. Squire, Isabela Werneck da Cunha et al.|Urology|2007Cited by 4
Clinical impact of PTEN genomic deletions and TMPRSS2-ERG gene fusions in prostate cancerMaisa Yoshimoto, Jeremy A. Squire, Fernando Augusto Soares et al.|Cancer Research|2007Cited by 0